Mortensen, Line Aas
Thiesson, Helle C.
Tougaard, Birgitte
Egfjord, Martin
Fischer, Anne Sophie Lind
Bistrup, Claus
Funding for this research was provided by:
Helen and Einar Bjørnows fund (04121)
Nyreforeningen
Overlægerådets Legatudvalg
Regionernes medicinpulje 2014 (14/217)
Kong Christian den Tiendes Fond (91/2012)
Odense Universitetshospital
Region Syddanmarks Forskningspulje (13/7233)
Dansk Nefrologisk Selskab
Region Syddanmarks PhD-pulje (13/7606)
Regionernes Medicinpulje 2016 (16/2885)
Lægeforeningen (2011-3271/480853-128)
Article History
Received: 21 December 2017
Accepted: 26 March 2018
First Online: 3 May 2018
Ethics approval and consent to participate
: The SPIREN trial has been approved by the Research Ethics Committee of Southern Denmark on the 24th of August 2011 (project ID: s-20110095, protocol version 2 (07/28/2011)). Oral and written informed consent to participation is obtained from all study participants by study personnel prior to any study related procedure. All participants receive both written and oral information about the study before giving consent. The trial is conducted according to the standards of Good Clinical Practice (GCP) and undergoes continuous monitoring by local GCP representatives.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.